glp-1 class diabetes drugs Comparing Ozempic, Wegovy and Other GLP-1 Drug Savings: A Complete

Starting with a lower dose and gradually increasing may improve tolerability

The condition is typically congenital, meaning it is present from birth

doi: 10.3389/fphar.2025.1737199 Received 01 November 2025 Revised 21 December 2025 Accepted 29 December 2025 Published 15 January 2026 Volume 16 - 2025 Edited by Dawei Chen, University of Kiel, Germany Reviewed by Eveljn Scarian, University of Pavia, Italy Hong Cheng, Yangzhou University, China Updates Copyright 2026 Knudsen, Tadje, Coggins and Venketaraman

At roughly one-quarter of a standard dose, a single Ozempic pen that normally lasts four weeks can last several months

Manages oxidative stress and reduces free radical damage

Ehrlich I, Malinow R (2004)